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INTRODUCTION 
 
Veterinarians are not primarily concerned with the 
increase in production by treating the sick animals and 
poultry but their important job is to ensure quality 
(residue free) edible animal products such as milk, meat 
and eggs to the public. The implementations of WTO 
regulations demand that veterinarians working in food 
animal medicine should learn how to avoid 
drug/chemical residues in food animals and disseminate 
this information to the farmers to safeguard the health 
of general public. This issue is also of paramount 
importance for the veterinarians employed in 
pharmaceutical and regulatory sectors responsible for 
assessing the fate of drugs and chemicals that enter the 
human food chain via the edible products. It is also 
need of the day that environmentalists, toxicologists 
and non government organizations (NGO) should pay 
due attention towards this issue. This is necessary to 
conduct complete risk assessment, risk management, 
risk communication studies and implement certain 
legislative measures to safeguard the public health.   
This article discusses some important issues in this 
context such as hazards of drug/chemical residues, 
modes of chemical exposure, establishment of 
maximum residue levels (MRL), withdrawal times 
(WDT) and limitations in residue analysis. 
 
HAZARDS OF DRUG RESIDUES 
 
Potentially, there are two types of hazards relating 
to drug residues i) direct and short term hazards, and ii) 
indirect and long term hazards. 
 
Direct and short term hazards 
Drugs used in food animals can affect the public 
health because of their secretion in edible animal tissues 
in trace amounts usually called residues. For example, 
oxytetracycline (Salehzadeh et al., 2006) and 
enrofloxacin residues (Salehzadeh et al., 2007) have 
been found above the maximun residual level in 
chicken tissues. Similarly, diclofenac residues were 
reported to be the cause of vulture population decline in 
Pakistan (Oaks et al., 2004). Some drugs have the 
potential to produce toxic reactions in consumers 
directly; for example, clenbutarol caused illness in 135 
peoples as a result of eating contaminated beef in Spain 
in 1990. Other types of drugs are able to produce 
allergic or hypersensitivity reactions. For example, 2-β 
lactam antibiotics can cause cutaneous eruptions, 
dermatitis, gastro-intestinal symptoms and anaphylaxis 
at very low doses. Such drugs include the penicillin and 
cephalosporin groups of antibiotics (Paige et al., 1997).   
 
Indirect and long term hazards 
Indirect and long term hazards include 
microbiological effects, carcinogenicity, reproductive 
effects and teratogenicity. Microbiological effects are 
one of the major health hazards in human beings. 
Antibiotic residues consumed along with edible tissues 
like milk, meat and eggs can produce resistance in 
bacterial populations in the consumers. This is one of 
the major reasons of therapeutic failures amongst such 
peoples. Certain drugs like 3-nitrofurans and 
nitroimidiazoles can cause cancer in human population. 
Similarly, some drugs can produce reproductive and 
teratogenic effects at very low doses consumed for a 
prolonged period of time. One such example is vaginal 
clear cell adenocarcinoma and benign structural 
abnormalities of uterus with diethyl stilbesterol 
(Sundlof, 1994). 
 
CHEMICAL RESIDUES 
 
Not only the drugs, but chemical residues are also 
hazardous to the public health. Pesticides are widely 
used in agriculture. It has been estimated that about 
three million cases of pesticide poisoning occur 
worldwide each year, with 220,000 deaths (UNEP, 
2004). Majority of these poisonings occur in developing 
countries due to less protection against exposure, 
ignorance from health risk and easy access to harmful 
chemicals. Pesticides have contributed to dramatic 
increase in crop yields and in the quantity and variety of 
the diet. Also, they have helped to limit the spread of 
certain diseases. But pesticides also have harmful 
effects; they can cause injury to human health as well as 
to the environment. The range of these adverse health 
effects includes: acute and persistent injury to the 
nervous system, lung damage, injury to the 
reproductive organs, dysfunctioning of the immune and 
endocrine systems, birth defects, and cancer. Problems 
associated with pesticide hazards to man and the 
environment are not confined to the developing 
countries. Developed nations have already suffered 
these problems, and are still facing some problems in 
certain locations. For many reasons, the severity of 
pesticide hazards is much pronounced in third world Pakistan Vet. J., 2009, 29(1): 42-46. 
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countries. A number of long persistent organochlorines 
and highly toxic organophosphates, which have been 
banned or severely restricted, are still marketed and 
used in many developing countries. The misuse of 
pesticides by concerned individuals, in addition to lack 
of or weak national controlling plans, is behind the 
outbreak of adverse effects in developing countries.  
 
A unique mode of chemical exposure 
There are basically three ways by which 
humans/animals are exposed to chemicals. One is 
ingestion of chemicals that is often very serious and 
may lead to death. Other is inhalation which is limited 
to only volatile chemicals. The third route of entry is 
dermal exposure and this is usually overlooked or 
underestimated mode of chemical entry to live bodies. 
But this should be taken as an important way as most of 
the environmentally toxic chemicals are highly 
lipophilic (have affinity for lipids). Such chemicals are 
capable of either binding to skin lipids or can extract 
the lipids out of the skin. In the first scenario, these 
chemicals can form skin depots and thus can act as slow 
releasing formulations. In the second scenario, these 
chemicals render the skin more permeable to similar or 
other types of toxic chemicals. This situation results in 
2-4 fold increase in the dermal absorption of jet fuel 
hydrocarbons through the skin that has been previously 
exposed to jet fuel for 1 and 4 days (Muhammad et al., 
2005a, 2005b).  
This scenario is important for occupational workers. 
For example, the crews working in jet engine wear fuel 
permeable cotton coveralls to reduce the possibility of 
explosion due to the generation of static electricity 
associated with more protective clothing. Daily 
exposure to fuels can result in saturation of the cotton 
cloth, resulting in an occluded environment for 
repeated, long-term exposure to the skin during the 
typical 8 hour workday (Allen et al., 2001). Chronic 
exposure to jet fuel has been shown to cause human 
liver dysfunction, emotional dysfunction, abnormal 
electroencephalograms, shortened attention spans, 
decrease sensorimotor speed and changes in immune 
functions (Harris et al., 2001). Repeated application of 
petroleum middle distillates to the skin causes chronic 
irritation and inflammation (Freeman et al., 1990). 
Fabric soaked with jet fuels for 4 days and evaluated on 
day 5 produced significant skin damage in pigs 
(Monteiro-Riviere  et al., 2001). The disruption of 
barrier function of skin, as indicated by an increase in 
trans-epidermal water loss after exposure to JP-8, might 
result in increased permeation to its own components 
and/or other chemicals exposed to skin (Monteiro-
Riviere  et al., 2001). Pre-exposure of skin to 
laurocapram, a compound similar to some of the JP-8 
performance additives, enhanced the penetration of 
sodium lauryl sulfate, suggesting that an increase in 
irritation at the exposed site is possible (Szolar-Platzer 
et al., 1996). These studies clearly indicate that 
environmental toxic agents have the potential to cause 
skin damage and thus render the skin more permeable 
to other toxic agents. 
No doubt, such chemicals are of direct health 
concern for health regulatory authorities. But at the 
same time the animals exposed to toxic chemicals may 
exhibit considerable residues in their edible products 
(milk, meat, eggs) and are thus an indirect threat to 
public health.  
 
How these issues can be handled? 
Such problems can be resolved by taking into 
consideration three steps i.e. risk assessment, risk 
management and risk communication. Basically, risk 
assessment is a systematic scientific characterization of 
potential adverse health effects following exposure to 
hazardous agents. Results from the risk assessment are 
used to inform risk management, who work with factors 
like social importance of risk, social acceptability of the 
risk, economic impacts etc. Finally, risk communication 
involves making the risk assessment and risk 
management information comprehensible to lawyers, 
politicians, judges, environmentalists and community 
groups. One basic step to build this foundation is the 
determination of residue levels in our foods.  
When the animal is slaughtered or its edible 
products are collected, there is a legal requirement that 
drug concentrations in these products are not at levels 
greater than those established as safe by the relevant 
regulatory authority in the country of origin. In many 
countries of the world, this upper level is referred to as 
the maximum residue level (MRL), while in United 
States it is termed as tolerance (Riviere, 1999).  
MRLs and tolerances are established by regulatory 
authorities based on many factors primarily relating to 
the safety of the animal product to the consumer, the 
usage pattern of the compound (pesticide in the field), 
and analytical methodology. The major determining 
factor is food safety. In this context, the focus is the 
length of time after discontinuation of drug 
administration or chemical exposure required to allow a 
tissue to deplete to a concentration below the MRL 
(Fitzpatrick et al., 1995). This is the pre-slaughter meat 
withdrawal time (WDT; Tables 1 and 2). If the matrix 
is milk, then the parameter of interest is the milk 
discard interval (MDI). This will be interesting to know 
that how is the tissue tolerance or MRL established.  
 
Maximum residue level  
The MRL or tolerance is the target concentration in 
a residue-depletion study. It should be established 
purely on the basis of safety to the person consuming 
the product and has no pharmacodynamic reality in the 
animal to which the drug has been administered. Tissue 
tolerances are normally established in fat, milk, muscle, 
liver, kidney, skin, or sometime meat by-products.Pakistan Vet. J., 2009, 29(1): 42-46. 
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       Table 1: Withdrawal times of some important drugs for dairy cows 
Drugs  *Preslaughter withdrawal 
(days) 
*Milk discard (days) 
        Injectables 
Ampicillin trihydrate    6    2 
Amoxicillin trihydrate  25    4 
Ceftiofur hydrochloride    2    0 
Ceftiofur sodium     0    0 
Erythromycin  14    3 
Furosemide    2    2 
Hydrochlorothiazide    0    3 
Isoflupredone acetate    7    0 
Oxytetracycline  28    4 
Procaine penicillin G  10    2 
Sulfadimethoxine    5  2.5 
Tripelennamine    4    1 
        Oral medications 
Chlorothiazide (bolus)    0    3 
Fenbendazole (suspension) 
(paste) 
  8 
  8 
  0 
  0 
Fenbendazole (blocks)  13    0 
Morantel tartrate (feed)  14    0 
Trichlormethazide + dexamethasone    0    3 
        Topical treatments (Dry cows only) 
Famphur  35  Do not use within 21 
days of application. 
Fenthion  35  Do not use within 28 
days of application. 
Phosmet    3  Do not use within 28 
days of application. 
Coumaphos    0  Do not use within 14 
days of application. 
        Intramammary application (Dry cow therapy)  
Benzathine cephapirin  42  72 hours 
Benzathine cloxacillin  30  - 
Erythromycin 14  36  hours 
Dihydrostreptomycin sulfate + procaine 
penicillin G 
60  Within 96 h after calving 
Novobiocin 30  - 
Novobiocin sodium + procaine penicillin  30  Within 72 h after calving 
Procaine penicillin G    4  Within 72 h after calving 
        Intramammary Application (Lactating cow therapy) 
Amoxicillin 12  60  hours 
Erythromycin 14  36  hours 
Novobiocin + procaine penicillin G  15  72 hours 
Pirlimycin 28  36  hours 
Potassium hetacillin  10  72 hours 
Procaine penicillin G    3  60 hours 
Salicylic acid  -  48 hours 
Sodium cephapirin    4  96 hours 
Sodium cloxacillin  10  48 hours 
        * Data obtained from Mississippi State University Extension Services, USA.
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Table 2: Withdrawal times of some important drugs 
for sheep and goats 
Drugs  *Preslaughter 
withdrawal (days) 
Oral medications 
Albendazole    7 
Ivermectin 11 
Levamisole hydrochloride    3 
Neomycin sulfate    2  
Feed medications 
Chlortetracycline    0 
Decoquinate    0 
Lasalocid    0 
Neomycin sulfate    2 
Water medications 
Neomycin sulfate    2 
Oxytetracycline    5 
Injectables 
Sodium selenite (Vitamine E/selenium)  14 
Ceftiofur sodium    0 
Erythromycin    3 
Procaine penicillin    9 
Topical treatments 
Cyano (3-phenoxyphenyl) methyl- ectrin 
4-chloro-alpha-(1-methylethyl) 
benzeneacetate  
  2 
Permethrin    0 
Miscellaneous  
Zeranol (implant pellet)  40 
Drugs labeled for use in goats  
Decoquinate (feed)    0 
Monensin (feed)    0 
Neomycin sulfate (feed)    3 
Neomycin sulfate (water)    3 
Neomycin sulfate (oral)    3 
* Data obtained from Mississippi State University 
Extension Services, USA. 
 
The first step in calculating the tolerance is to 
determine the safe concentration of drug that could be 
consumed by individuals eating the animal products: 
 
Safe concentration = (ADI) (Body weight)/ 
Food consumption factor 
 
In this equation, ADI refers to acceptable daily 
intake which is the maximum amount of chemical 
(mg/kg) that may be consumed daily over a lifetime 
without producing an adverse effect. Body weight is the 
average weight of humans consuming the product 
(usually assumed to be 60 Kg). The food consumption 
factor is the amount of edible product estimated to be 
consumed daily by an individual.  The food 
consumption factor is based upon the average 
individual’s daily intake of different types of foods. The 
Food and Drug Administration (FDA) and other 
regulatory agencies have tabulated food-specific 
consumption factors. Examples (Kg consumed per day) 
are 0.3 for muscle, 0.1 for liver, 0.05 for kidney, 0.05 
for fat, and 1.5 for milk in USA (Riviere, 1999). The 
milk consumption in children is especially high since 
the total diet for an infant may entirely be the milk. 
Other countries use similar food consumption factors 
but distribute the ADI based on independent organ 
consumption data.  
The most controversial component in this 
calculation is the establishment of ADI, which involves 
the risk assessment extrapolation from laboratory 
animal toxicology studies. ADI is estimated as a 
fraction of the no-observed-adverse-effect-level 
(NOAEL) determined from standardized long-term 
laboratory animal toxicological studies conducted in at 
least two animal species. The NOAEL is then divided 
by a safety factor ranging from 100 to 1000, depending 
on the nature of the compound’s toxicology or the 
strength of the data. Part of this factor is to account for 
the vagaries of interspecies extrapolations (rodent to 
human) and to be conservative in the face of more acute 
and serious toxicity (teratogens, hypersensitivity, etc.). 
The FDA uses a safety factor of 100 for a chronic study 
and 1000 for a 90-day toxicity study. This can be 
appreciated that the safety factor is greater when there 
is evidence of teratogenic effects or when a more 
economical subchronic (90-day) study is submitted in 
place of a more complete chronic study. This latter 
factor alone can result in a 10 fold lower tolerance (and 
hence longer withdrawal time) being established for a 
product supported by 90-day studies compared to the 
identical formulation supported by a chronic study 
(Concordet and Toutain, 1997). Thus, a subjective bias 
is directly built into the analysis that is independent of 
the actual toxicological properties of the compound.  
The final step is to establish the tolerance. The safe 
concentration is based upon the total concentration of 
drug (total residues), which includes the parent drug 
and any metabolites. Some special regulations apply for 
covalently bound residues (Lu et al., 1988). Depending 
on the drug, bound residues may be included as either a 
component of the total or a fraction removed from 
consideration. A marker residue is now selected that 
has a defined relationship to the total residues. If the 
drug is not metabolized, the safe concentration becomes 
the tolerance. If the drug is metabolized, the tolerance 
will be a fraction of the safe concentration. In many 
other countries, the process of establishing MRLs is 
very similar to the above mentioned protocols with very 
few exceptions.  
 
Psychological/sociological considerations 
In order to establish a firm base to resolve the 
above mentioned issues, certain aesthetic considera- 
tions, risks perceived by the public, sensitive 
populations and issues, international relations and trade 
barriers have to be considered. There is an urgent need Pakistan Vet. J., 2009, 29(1): 42-46. 
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for comprehensive anthropological studies to prioritize 
the issues and their solutions. 
 
Limitations in residue analysis 
One basic limitation to conduct residue and risk 
analysis is the detection of chemical residues in edible 
animal products. With out accurate detection, exact risk 
is impossible to assess. This process needs highly 
qualified expertise, sensitive instruments and modern 
analytical techniques. High Performance Liquid 
Chromatography (HPLC), Gas Chromatography (GC) 
and Mass Spectrometry (MS) are sensitive instruments 
while Solid Phase Micro-extraction (SPME) and 
Microdialysis are modern analytical techniques used for 
residue analysis. 
 
Conclusions 
Veterinarians must be well aware of the importance 
of drug/chemical residues in the food animals and their 
possible risk to the general public. They must have 
updated information about the proper withdrawal times 
of all the drugs/chemicals used in their areas of 
practice. They must extend this information to the 
livestock and poultry farmers for the production of 
residue free edible animal products like milk, meet and 
eggs. For residue analysis, trained manpower are 
needed. In this regard, the availability of sensitive 
equipment and modern analytical techniques are of 
paramount importance.  
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